-
1
المؤلفون: Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut, Véronique Hentgen
المساهمون: Centre Hospitalier de Versailles André Mignot (CHV), Service de Médecine Interne [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Lausanne University Hospital, Centre Hospitalier Universitaire [Grenoble] (CHU), Service de néphrologie, rhumatologie et dermatologie pédiatriques [Hôpital Femme Mère Enfant, HCL], Hospices Civils de Lyon (HCL)-Hôpital Mère Enfant, CHU Bordeaux [Bordeaux], Département de pédiatrie [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de Bordeaux Pellegrin [Bordeaux], University Children’s Hospital Basel = Hôpital pédiatrique universitaire des deux Bâle [Bâle, Suisse] (UKBB), Service de Rhumatologie [CHU Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre
المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in immunology, vol. 12, pp. 744780
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.744780⟩مصطلحات موضوعية: Male, Familial Mediterranean fever, interleukin-1 blockers, Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized/therapeutic use, Antirheumatic Agents/therapeutic use, Child, Child, Preschool, Female, Hereditary Autoinflammatory Diseases/complications, Hereditary Autoinflammatory Diseases/drug therapy, Humans, Infant, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/antagonists & inhibitors, Middle Aged, Retrospective Studies, Young Adult, anakinra, autoinflammatory diseases, canakinumab, hereditary recurrent fevers, indications, treatment, 0302 clinical medicine, Quality of life, Immunology and Allergy, Original Research, 0303 health sciences, Mevalonate kinase deficiency, Interleukin, 3. Good health, Antirheumatic Agents, [SDV.IMM]Life Sciences [q-bio]/Immunology, medicine.drug, medicine.medical_specialty, Immunology, MEDLINE, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, 030304 developmental biology, 030203 arthritis & rheumatology, Anakinra, business.industry, Hereditary Autoinflammatory Diseases, RC581-607, medicine.disease, Canakinumab, Interleukin 1 Receptor Antagonist Protein, Immunologic diseases. Allergy, Complication, business, Interleukin-1
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e625e3774c42c4cbcb268ba3e8a594dTest
https://www.frontiersin.org/articles/10.3389/fimmu.2021.744780/fullTest -
2
المؤلفون: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L, Dis, Biologics Children Rheumatic
المساهمون: Public Health Sciences
المصدر: Rheumatology (Oxford, England)
RHEUMATOLOGY
Kearsley-Fleet, L, Beresford, M W, Davies, R, De Cock, D, Baildam, E, Foster, H E, Southwood, T R, Thomson, W, Hyrich, K L & Biologics for Children with Rheumatic Diseases Study (BCRD) 2019, ' Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra ', Rheumatology (Oxford), vol. 58, no. 1, pp. 94-102 . https://doi.org/10.1093/rheumatology/key262Testمصطلحات موضوعية: Male, Time Factors, Epidemiology, Arthritis, Antirheumatic Agents/therapeutic use, Outcome measures, Severity of Illness Index, Biologic Therapies, chemistry.chemical_compound, 0302 clinical medicine, Pharmacology (medical), Arthritis, Juvenile/drug therapy, 030212 general & internal medicine, Child, skin and connective tissue diseases, Statistics, Induction Chemotherapy, Clinical Science, Treatment Outcome, Antibodies, Monoclonal, Humanized/therapeutic use, statistics, Antirheumatic Agents, Child, Preschool, Cohort, epidemiology, Female, Biological Products/therapeutic use, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Interleukin 1 Receptor Antagonist Protein/therapeutic use, outcome measures, 03 medical and health sciences, Tocilizumab, Rheumatology, biologic therapies, Internal medicine, Severity of illness, medicine, Humans, Juvenile Idiopathic Arthritis, JIA, 030203 arthritis & rheumatology, Biological Products, Anakinra, business.industry, Induction chemotherapy, medicine.disease, Arthritis, Juvenile, Interleukin 1 Receptor Antagonist Protein, Logistic Models, chemistry, Macrophage activation syndrome, business
وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89dce7fd1afb5b2ae4989dbed4d264Test
https://doi.org/10.1093/rheumatology/key262Test -
3
المؤلفون: K.H. Ly, Marc Michel, Olivier Fain, Jérôme Stirnemann, Eric Liozon, Anne-Laure Fauchais
المصدر: Joint, Bone, Spine, Vol. 81, No 1 (2014) pp. 76-78
مصطلحات موضوعية: Glucocorticoids/therapeutic use, Male, Pathology, medicine.medical_specialty, Intimal hyperplasia, Giant Cell Arteritis, Inflammation, Antirheumatic Agents/therapeutic use, Interleukin-1/antagonists & inhibitors, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Pathogenesis, Rheumatology, medicine, Giant Cell Arteritis/drug therapy/radionuclide imaging, Humans, Glucocorticoids, Aged, Aged, 80 and over, Anakinra, business.industry, medicine.disease, Arterial occlusion, Giant cell arteritis, Interleukin 1 Receptor Antagonist Protein, Antirheumatic Agents, Positron-Emission Tomography, Tumor necrosis factor alpha, Female, medicine.symptom, Vasculitis, business, medicine.drug, Interleukin-1
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3894ab9620b3e20fe15bf61de2609808Test
https://archive-ouverte.unige.ch/unige:78459Test -
4
المؤلفون: Gaby Palmer, Cem Gabay, Nadia Announ, Pierre-André Guerne
المصدر: Joint, Bone, Spine, Vol. 76, No 4 (2009) pp. 424-426
مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Anti-Inflammatory Agents, Non-Steroidal/*contraindications, medicine.medical_treatment, Arthritis, Chondrocalcinosis, Inflammation, Interleukin-1/antagonists & inhibitors, Interleukin 1 Receptor Antagonist Protein/*therapeutic use, Rheumatology, Internal medicine, medicine, Humans, Antirheumatic Agents/*therapeutic use, Aged, ddc:616, Anakinra, Kidney Failure, Chronic/*complications, business.industry, Contraindications, Anti-Inflammatory Agents, Non-Steroidal, Interleukin, medicine.disease, Surgery, Chondrocalcinosis/complications/*drug therapy/*prevention & control, Interleukin 1 Receptor Antagonist Protein, Treatment Outcome, Antirheumatic Agents, End stage renal failure, Kidney Failure, Chronic, Hemodialysis, Pseudogout, medicine.symptom, business, Interleukin-1, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042d68687a7e4728729ac4008c49ab75Test
https://archive-ouverte.unige.ch/unige:19639Test